CEO Doug Murphy-Chutorian has expressed strong enthusiasm for the company's commitment to an aggressive Bitcoin treasury strategy, emphasizing its importance in financial planning.

The Bitcoin market has experienced significant growth, increasing by 55.10% since the 2024 US election, benefiting companies like Semler that adopt a Bitcoin treasury strategy.

Semler Scientific, founded in 2007 and listed on the Nasdaq since 2014 under the ticker SMLR, specializes in healthcare products for chronic disease diagnosis and treatment.

The company is planning to raise $75 million through a private offering of convertible senior notes maturing in 2030, with proceeds aimed at acquiring more Bitcoin.

On January 13, Semler acquired 237 BTC, raising its total Bitcoin holdings to 2,321 BTC, valued at approximately $241 million as Bitcoin trades around $105,000.

To mitigate stock dilution from note conversions, Semler plans to engage in capped call transactions with financial institutions.

Following the announcement of the bond offering, Semler's stock declined by 12.5%, reflecting investor concerns over potential share dilution despite the company's Bitcoin gains.

The new bond offering targets qualified institutional buyers under Rule 144A of the Securities Act of 1933, with interest payable semi-annually.

Semler's investment in Bitcoin began in May 2024, reflecting a broader trend among public companies seeking potential gains from cryptocurrency.

In the fourth quarter of 2024, Semler Scientific reported an unrealized profit of $28.9 million from its Bitcoin holdings.

For the fourth quarter, Semler estimated revenue between $12.1 million and $12.5 million, with operating income ranging from $3.4 million to $3.7 million.

Despite a 38% increase in SMLR shares over the past year, the stock remains significantly below its all-time high of $149.99 reached in October 2021.